Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

C 1311

Known as: C-1311, C1311 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
PURPOSE C-1311 is a member of the novel imidazoacridinone family of anticancer agents. This phase 1 trial was designed to… Expand
Is this relevant?
Highly Cited
2007
Highly Cited
2007
Cell-based assays are more complex than cell-free test systems but still reflect a highly artificial cellular environment… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2007
2007
Imidazoacridinone C-1311 is a DNA-targeting antitumor intercalator/alkylator currently undergoing Phase II clinical trials. Here… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2006
2006
We describe a modified hollow fibre assay (HFA) for investigating the potential of novel molecules as pharmaceutical agents. In… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2005
2005
In this study, we investigated the cell death process induced by imidazoacridone C-1311 (Symadex) in HT-29 human colon carcinoma… Expand
Is this relevant?
2003
2003
The imidazoacridinone derivative, C-1311, is an antitumor agent that has been under phase I of clinical trial. The work presented… Expand
Is this relevant?
2001
2001
The imidazoacridinone derivative, C-1311, is a new antitumour agent that exhibits strong antitumour activity against experimental… Expand
Is this relevant?
1998
1998
Abstract C1311 is the most active member of a new series of rationally designed anti-cancer agents, the imidazoacridinones, which… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
1996
1996
We have studied the actions of C-1311, an imidazoacridinone analogue with potent in vivo antitumour activity, against a human… Expand
  • figure 1
  • figure 2
  • figure 3
  • table I
  • table II
Is this relevant?
1996
1996
Novel imidazoacridinone derivatives, C1310 and C1311, have been evaluated for their potential to inhibit tumour cell growth in… Expand
  • figure 1
  • table I
  • table II
  • figure 2
  • figure 3
Is this relevant?